Testing for antimicrobial activity against multi-resistant Acinetobacter baumannii. For. Forbo Flooring B.V. Final Report. Work Carried Out By

Similar documents
Quality assurance of antimicrobial susceptibility testing

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

ANTIMICROBIAL RESISTANCE IN COMMENSAL E. COLI FROM LIVESTOCK IN BELGIUM: Veterinary Epidemiology

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

New Washable SPILLSEAL Keyboards. How they can reduce MRSA in your hospital

Official Journal of the European Union L 162/3

International Journal of Antimicrobial Agents

International Journal of Health Sciences and Research ISSN:

Version 1.01 (01/10/2016)

EARS Net Report, Quarter

Available online at ISSN No:

ESCMID Online Lecture Library. by author

Redefining Infection Management. Proven Clinical Outcomes

Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Queen s Medical Centre, Nottingham, UK

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

A. P. MacGowan*, M. Wootton, A. J. Hedges, K. E. Bowker, H. A. Holt and D. S. Reeves

Antimicrobial Stewardship Strategy: Antibiograms

UDC: : :579.22/ :615.28

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GENERAL NOTES: 2016 site of infection type of organism location of the patient

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

MRSA surveillance 2014: Poultry

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

The relevance of Gram-negative pathogens for public health situation in India

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Reduce the risk of recurrence Clear bacterial infections fast and thoroughly

2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

2015 Antimicrobial Susceptibility Report

FIS Resistance Surveillance: The UK Landscape. Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Multidrug-Resistant Acinetobacter

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S

Appropriate antimicrobial therapy in HAP: What does this mean?

Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Isolation of Urinary Tract Pathogens and Study of their Drug Susceptibility Patterns

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Considerations in antimicrobial prescribing Perspective: drug resistance

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Available online at Scholars Research Library. Der Pharmacia Lettre, 2017, 9 (1):85-92

ORIGINAL ARTICLE /j x. Mallorca, Spain

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

General Approach to Infectious Diseases

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

EFSA s activities on Antimicrobial Resistance

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

European Committee on Antimicrobial Susceptibility Testing

ACINETOBACTER SPECIES: PHENOTYPIC CHARACTERIZATION AND ANTIMICROBIAL RESISTANCE

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

REPORT OF THE NATIONAL EPIDEMIOLOGIC SURVEY OF ENTEROBACTER AEROGENES IN BELGIAN HOSPITALS IN

microbiology testing services

Infection Control Priorities for Antibiotics Resistance - The Search and Destroy Strategy. WH Seto Hong Kong China

Whitechapel, London E1 1BB, UK. Hammersmith Campus, London W12 0NN, UK. Queen Mary s School of Medicine and Dentistry, London E1 2AT, UK

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Temporal Evaluation of Antibiotic Resistance from Common Bottlenose Dolphin (Tursiops truncatus), a Sentinel Species

EUCAST recommended strains for internal quality control

Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA

= 0.5 mg. In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1.

MALAYSIA NATIONAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE (AMR) ANIMAL HEALTH

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

European Committee on Antimicrobial Susceptibility Testing

Endemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

CONTAGIOUS COMMENTS Department of Epidemiology

Please distribute a copy of this information to each provider in your organization.

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

Transcription:

Technical Report Testing for antimicrobial activity against multi-resistant Acinetobacter baumannii For Forbo Flooring B.V. Final Report Work Carried Out By A. Smith Group Leader Peter Collins PRA Ref: 75221-244 09 October 2012 Global Surface Coatings Covered

Final Report Page 1 of 4 PRA Ref. Number 75221-244 Date Received 04 September 2012 Date Issued 09 October 2012 Client Forbo Flooring B.V. Industrieweg 12 1566 JP Assendelft Netherlands FAO: Jose Jak Work Requested Samples Submitted Testing for antimicrobial activity against multi-resistant Acinetobacter baumannii Replicate samples of linoleum floor covering Work Carried out by.. A. Smith Approved by.. P. Collins, T. Glazier Authorised Signatory PRA Coatings Technology Centre 14 Castle Mews, High Street, Hampton Middlesex TW12 2NP, United Kingdom www.pra-world.com Coatings@pra-world.com T: + 44 (0)20 8487 0800 F: + 44 (0)20 8487 0801 The Paint Research Association Company limited by Guarantee Registered office as opposite Registered in England No. 216387

75221-244 Final Report Page 2 of 4 1 Materials Submitted For Testing Replicate samples of a linoleum floor covering were submitted to be tested for antimicrobial activity against a multi-resistant strain of Acinetobacter baumannii, using a procedure based on ISO 22196: 2011 (Plastics Measurement of antibacterial activity on plastics and other non-porous surfaces). 2 Test Organism A culture of Acinetobacter baumannii strain NCTC 13420 was obtained from the HPA Culture Collection. This organism is described as being multi-resistant and is detailed in the following paper A prevalent, multi-resistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect. 2004 Nov;58(3):170-9. Coelho JM, Turton JF, Kaufmann ME, Glover J, Woodford N, Warner M, Palepou MF, Pike R, Pitt TL, Patel BC, Livermore DM - Specialist and Reference Microbiology Division, Laboratory of Healthcare Associated Infection, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK. Abstract: A multi-resistant clone of Acinetobacter baumannii was identified in 24 hospitals in the UK, predominantly in the London area, over a period of three years. Isolates were characterized by distinctive ApaI macrorestriction profiles, as resolved by pulsed-field gel electrophoresis (PFGE), which all clustered within 80% similarity using a 1% band position tolerance setting. The first isolates identified were received by the reference laboratories in April 2000, and by June 2003, a total of 375 isolates with similar PFGE profiles from 310 patients from 24 hospitals had been received. The isolates originated mainly from sputum and wound specimens, with the majority from patients in intensive care units. Amplified fragment length polymorphism analysis of a subset of isolates showed that they clustered closely, supporting the PFGE results. All the isolates tested were highly resistant to ampicillin, piperacillin, piperacillin/tazobactam, ceftazidime, cefotaxime, gentamicin and ciprofloxacin, and most isolates were carbapenem resistant. Amikacin sensitivity varied from susceptible [minimum inhibitory concentration (MIC) <or= 4 mg/l] to highly resistant (MIC >256 mg/l) 3 Test Procedure Testing was carried out using a procedure based on ISO 22196: 2011 (formerly JIS Z 2801: 2000). 0.1ml of a suspension containing approx. 5 x 10 5 cells of the test organism was placed on the upper surface of triplicate test samples (60mm x 60mm) and on triplicate samples of polystyrene sheet (used as the PRA control and known to have no antimicrobial activity).

75221-244 Final Report Page 3 of 4 The suspension was held in intimate contact with the test and control surfaces using a polyethylene film rectangle, 20mm x 20mm in size. To provide a time zero inoculation level, an additional triplicate set of PRA control samples (polypropylene film) were similarly inoculated, and the inoculum then immediately recovered from the surface using the method described below. The remaining replicates were incubated at 21 C and relative humidity of not less than 90%. After 24 hours incubation the inoculum was removed from the test surfaces (again using the method described below) and bacterial counts determined. Owing to the porosity of the underlying surface of the test sample a modified procedure developed by the International Biodeterioration Research Group (IBRG) was used to recover the inoculum from the surfaces of the control pieces (at time zero and after 24 hours) and the test pieces (after 24 hours). The polyethylene film covering the inoculum was removed with sterile forceps and placed in 10 ml of sterile neutralising medium. The surface which had been covered by the film was then thoroughly cleaned using a sterile cotton swab, and the untouched portion of this broken off into the neutralising medium. After vigorous agitation bacterial counts were determined on the washings. 4 Results and Observations The microbial counts obtained (shown as a geometric mean), together with the antimicrobial activity (shown as a Log 10 reduction) and the % kill, are given in the Table. The antimicrobial activity was calculated as follows: R = [log (B/A) - log (C/A) = [log (B/C)] where, R = antimicrobial activity A = mean microbial count on PRA control sample at time zero B = mean microbial count on PRA control sample after 24 hours C = mean microbial count on test piece after 24 hours Table : Antimicrobial activity against Acinetobacter baumannii NCTC 13420 Test Sample Mean Count Antimicrobial Activity % Kill Initial count 24 hr count PRA Control 6.1 x 10 5 5.4 x 10 5 - - Linoleum Floor Covering - <10 >4.7 >99.9

75221-244 Final Report Page 4 of 4 5 Conclusion The ISO standard 22196: 2011 specifies a method of evaluating the antimicrobial activity of antimicrobial-treated materials. The predecessor to this ISO standard, JIS Z 2801: 2000, stated that for a coating to demonstrate antimicrobial efficacy the value of the antimicrobial activity shall not be less than 2.0. The ISO standard provides a means of quantifying the antimicrobial effectiveness of a surface in terms of antimicrobial activity, but no longer specifies a value for determining antimicrobial efficacy. As a pass/ fail criterion is not defined in the current standard, PRA uses the following criterion to comment on the level of activity determined. Antibacterial Activity % Kill Comment <1.5 <96.8 poor 1.5 2.0 96.8-99.0 borderline 2.0-3.0 >99.0-99.9 good >3.0 >99.9 excellent Referring to the Table, the linoleum floor covering demonstrated excellent antimicrobial activity against the multi-resistant strain of Acinetobacter baumannii. End of Report

www.pra-world.com/technical PRA Coatings Technology Centre, 14 Castle Mews, High Street, Hampton, Middlesex, TW12 2NP, UK T: +44 (0)20 8487 0800 F: +44 (0)20 8487 0801 E: coatings@pra-world.com